---
input_text: 'Detecting Graft-Derived Cell-Free DNA Through Amplification Refractory
  Mutation System Polymerase Chain Reaction in Living-Donor Liver Transplantation:
  Report of 2 Cases. Graft-derived cell-free DNA (Gcf-DNA) is a non-invasive biomarker
  to monitor graft function. There are different methods to quantify Gcf-DNA, such
  as the classical Y-chromosome method and the latest digital droplet polymerase chain
  reaction method. In this study, we reported 2 patients genetically diagnosed with
  propionic acidemia (PA) went through living-donor liver transplantation (LDLT),
  and monitoring the change of Gcf-DNA examined by the amplification refractory mutation
  system polymerase chain reaction (ARMS-PCR) method. Two patients went through the
  operation successfully, and a 5 mL whole blood specimen was collected at 6 specific
  time points (day 0, day 1, day 7, day 14, day 30, day 60). The comparison of Gcf-DNA
  and the routine liver function showed that they have similar change-tendency curves,
  with the curves reaching the top at day 1 because of ischemia-reperfusion injury
  and generally declining from day 7-day 60 along with recovery of the patient. Applying
  the ARMS-PCR method to detect Gcf-DNA can be done without knowing the donor information
  and is not limited by donor-recipient-sex-mismatch condition. In conclusion, Gcf-DNA
  is a promising biomarker that can monitor graft function in LDLT, and we will apply
  it in more samples and observe it long term to validate its efficiency in the future.'
raw_completion_output: |-
  primary_disease: propionic acidemia (PA)
  medical_actions: living-donor liver transplantation (LDLT); monitoring graft function with Gcf-DNA; collecting whole blood specimen; comparing Gcf-DNA with routine liver function; applying the ARMS-PCR method
  symptoms: ischemia-reperfusion injury
  chemicals: 
  action_annotation_relationships: living-donor liver transplantation (LDLT) TREATS propionic acidemia (PA) IN propionic acidemia (PA); monitoring graft function with Gcf-DNA TREATS ischemia-reperfusion injury IN propionic acidemia (PA); comparing Gcf-DNA with routine liver function PREVENTS symptom worsening IN propionic acidemia (PA); applying the ARMS-PCR method PREVENTS graft dysfunction IN propionic acidemia (PA)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  applying the ARMS-PCR method PREVENTS graft dysfunction IN propionic acidemia (PA)

  ===

extracted_object:
  primary_disease: MONDO:0011628
  medical_actions:
    - living-donor liver transplantation (LDLT)
    - monitoring graft function with Gcf-DNA
    - collecting whole blood specimen
    - comparing Gcf-DNA with routine liver function
    - applying the ARMS-PCR method
  symptoms:
    - ischemia-reperfusion injury
  action_annotation_relationships:
    - subject: living-donor liver transplantation (LDLT)
      predicate: TREATS
      object: HP:0003571
      qualifier: MONDO:0011628
    - subject: monitoring graft function
      predicate: TREATS
      object: ischemia-reperfusion injury
      qualifier: MONDO:0011628
      subject_extension: Gcf-DNA
    - subject: routine liver function
      predicate: PREVENTS
      object: symptom worsening
      qualifier: MONDO:0011628
      subject_qualifier: comparing
      subject_extension: Gcf-DNA
    - subject: applying the ARMS-PCR method
      predicate: PREVENTS
      object: graft dysfunction
      qualifier: MONDO:0011628
      subject_extension: ARMS-PCR method
named_entities:
  - id: MONDO:0010184
    label: methylmalonic acidemia (MMA); propionic acidemia; cobalamin C (cblC) deficiency
  - id: CHEBI:15603
    label: leucine (Leu)
  - id: CHEBI:16414
    label: valine (Val)
  - id: CHEBI:17191
    label: isoleucine (Ile)
  - id: CHEBI:16044
    label: methionine (Met)
  - id: MONDO:0002012
    label: methylmalonic acidemia (MMA)
  - id: MONDO:0011628
    label: propionic acidemia
  - id: CHEBI:25017
    label: leucine
  - id: MAXO:0001175
    label: liver transplantation
  - id: HP:0001638
    label: cardiomyopathy
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0019052
    label: Inborn errors of metabolism (IEMs)
  - id: MAXO:0010039
    label: organ transplantation
  - id: HP:0001942
    label: metabolic acidosis
  - id: HP:0001987
    label: hyperammonemia
  - id: HP:0003571
    label: Propionic acidemia
  - id: HP:0001695
    label: cardiac arrest
  - id: HP:0001263
    label: Developmental delay
  - id: CHEBI:15428
    label: Glycine
  - id: CHEBI:28867
    label: Propionylcarnitine
  - id: HP:0001138
    label: optic neuropathy
  - id: HP:0000083
    label: Renal failure
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: MAXO:0000950
    label: Supportive care
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0001250
    label: seizures
  - id: HP:0002071
    label: extrapyramidal symptoms
  - id: HP:0001733
    label: pancreatitis
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:22586
    label: antioxidants
  - id: MONDO:0009563
    label: Maple Syrup Urine Disease (MSUD)
  - id: CHEBI:15539
    label: propionyl-CoA
  - id: CHEBI:33709
    label: amino acids
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:36080
    label: protein
  - id: MONDO:0000688
    label: organic acidemias
  - id: HP:0008281
    label: Acute hyperammonemia
  - id: CHEBI:26708
    label: NA
  - id: HP:0002829
    label: arthralgia
  - id: HP:0001410
    label: liver dysfunction
  - id: HP:0001919
    label: acute renal failure
  - id: HP:0033677
    label: ARDS
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:35341
    label: steroid
  - id: MAXO:0010032
    label: Heart transplantation
  - id: HP:0001644
    label: Dilated cardiomyopathy (DCM)
  - id: HP:0012758
    label: Neurodevelopmental delay
  - id: CHEBI:17272
    label: propionate
  - id: CHEBI:16510
    label: 3-hydroxypropionate (3HP)
  - id: CHEBI:28938
    label: ammonium
  - id: MONDO:0008723
    label: Very-Long Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)
  - id: HP:0001903
    label: anemia
  - id: HP:0011874
    label: hepatic arterial thrombosis (HAT)
